• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中 cDC1 失调:干预的机会。

cDC1 dysregulation in cancer: An opportunity for intervention.

机构信息

Department of Pathology, University of Chicago, Chicago, IL.

Department of Medicine, University of Chicago, Chicago, IL.

出版信息

J Exp Med. 2020 Aug 3;217(8). doi: 10.1084/jem.20200816.

DOI:10.1084/jem.20200816
PMID:32697286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7398176/
Abstract

Conventional dendritic cells driven by the transcription factor Batf3 (cDC1 cells) are critical for the activation and maintenance of tumor-specific CD8+ T cells. In this issue of JEM, Lin et al. (https://doi.org/10.1084/jem.20190673) demonstrate systemic dysfunction of cDC1 cells in pancreatic cancer, which offers potential treatment strategies to expand the benefit of checkpoint blockade immunotherapy.

摘要

转录因子 Batf3 驱动的传统树突状细胞(cDC1 细胞)对于肿瘤特异性 CD8+ T 细胞的激活和维持至关重要。在本期《JEM》中,Lin 等人(https://doi.org/10.1084/jem.20190673)证明了胰腺癌细胞中 cDC1 细胞的全身功能障碍,这为扩大检查点阻断免疫疗法的获益提供了潜在的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e841/7398176/b88738c48034/JEM_20200816_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e841/7398176/991ebf7a921f/JEM_20200816_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e841/7398176/b88738c48034/JEM_20200816_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e841/7398176/991ebf7a921f/JEM_20200816_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e841/7398176/b88738c48034/JEM_20200816_Fig2.jpg

相似文献

1
cDC1 dysregulation in cancer: An opportunity for intervention.癌症中 cDC1 失调:干预的机会。
J Exp Med. 2020 Aug 3;217(8). doi: 10.1084/jem.20200816.
2
Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis.1 型传统树突状细胞在胰腺癌发生的早期就出现系统性失调。
J Exp Med. 2020 Aug 3;217(8). doi: 10.1084/jem.20190673.
3
Concise review: The heterogenous roles of BATF3 in cancer oncogenesis and dendritic cells and T cells differentiation and function considering the importance of BATF3-dependent dendritic cells.简明回顾:考虑到依赖 BATF3 的树突状细胞的重要性,BATF3 在癌症发生和树突状细胞与 T 细胞分化和功能中的异质作用。
Immunogenetics. 2024 Apr;76(2):75-91. doi: 10.1007/s00251-024-01335-x. Epub 2024 Feb 15.
4
Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy.在已建立的肿瘤中耗尽常规型 1 型树突状细胞会抑制免疫疗法的疗效。
Cancer Res. 2022 Dec 2;82(23):4373-4385. doi: 10.1158/0008-5472.CAN-22-1046.
5
Conventional type 1 dendritic cells (cDC1) in cancer immunity.癌症免疫中的传统型 1 树突状细胞(cDC1)。
Biol Direct. 2023 Nov 1;18(1):71. doi: 10.1186/s13062-023-00430-5.
6
-Dependent Genes Control Tumor Rejection Induced by Dendritic Cells Independently of Cross-Presentation.依赖基因独立于交叉呈递控制树突状细胞诱导的肿瘤排斥
Cancer Immunol Res. 2019 Jan;7(1):29-39. doi: 10.1158/2326-6066.CIR-18-0138. Epub 2018 Nov 27.
7
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses.肿瘤源性前列腺素 E2 程序性调控 cDC1 功能障碍,从而损害抗肿瘤 T 细胞反应在肿瘤内的协调作用。
Immunity. 2023 Jun 13;56(6):1341-1358.e11. doi: 10.1016/j.immuni.2023.05.011.
8
Single-cell transcriptional profiling informs efficient reprogramming of human somatic cells to cross-presenting dendritic cells.单细胞转录组谱分析指导高效重编程人源体细胞为交叉呈递树突状细胞。
Sci Immunol. 2022 Mar 4;7(69):eabg5539. doi: 10.1126/sciimmunol.abg5539.
9
Distinct myeloid antigen-presenting cells dictate differential fates of tumor-specific CD8+ T cells in pancreatic cancer.不同的髓系抗原呈递细胞决定了胰腺癌细胞中肿瘤特异性 CD8+ T 细胞的不同命运。
JCI Insight. 2022 Apr 8;7(7):e151593. doi: 10.1172/jci.insight.151593.
10
Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus-Derived Vectors Fosters Dendritic Cell-Mediated T-cell Cross-Priming.重组 Semliki Forest 病毒载体介导 XCL1 和 sFlt3L 瘤内免疫治疗促进树突状细胞介导的 T 细胞交叉呈递。
Cancer Res. 2018 Dec 1;78(23):6643-6654. doi: 10.1158/0008-5472.CAN-18-0933. Epub 2018 Oct 8.

引用本文的文献

1
Comprehensive immunophenotyping reveals distinct tumor microenvironment alterations in anti-PD-1 sensitive and resistant syngeneic mouse model.全面免疫表型分析揭示了抗PD-1敏感和耐药同基因小鼠模型中不同的肿瘤微环境改变。
Sci Rep. 2025 Mar 10;15(1):8311. doi: 10.1038/s41598-025-91979-w.
2
Dendritic Cell Plasticity, Radiation, and Newton's Third Law.树突状细胞的可塑性、辐射和牛顿第三定律。
Clin Cancer Res. 2024 Oct 1;30(19):4260-4262. doi: 10.1158/1078-0432.CCR-24-1506.
3
In Vivo Stimulation of Therapeutic Antigen-Specific T Cells in an Artificial Lymph Node Matrix.

本文引用的文献

1
Mechanisms regulating T-cell infiltration and activity in solid tumors.调控实体瘤中 T 细胞浸润和活性的机制。
Ann Oncol. 2017 Dec 1;28(suppl_12):xii18-xii32. doi: 10.1093/annonc/mdx238.
2
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.肿瘤驻留的Batf3树突状细胞是效应T细胞转运和过继性T细胞治疗所必需的。
Cancer Cell. 2017 May 8;31(5):711-723.e4. doi: 10.1016/j.ccell.2017.04.003.
3
Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma.
在人工淋巴结基质中体内刺激治疗性抗原特异性 T 细胞。
Adv Mater. 2024 Jun;36(23):e2310043. doi: 10.1002/adma.202310043. Epub 2024 Mar 1.
4
Tolerogenic dendritic cells in radiation-induced lung injury.辐射诱导肺损伤中的耐受性树突状细胞。
Front Immunol. 2024 Jan 8;14:1323676. doi: 10.3389/fimmu.2023.1323676. eCollection 2023.
5
The DC-T cell axis is an effective target for the treatment of non-small cell lung cancer.DC-T 细胞轴是非小细胞肺癌治疗的有效靶点。
Immun Inflamm Dis. 2023 Nov;11(11):e1099. doi: 10.1002/iid3.1099.
6
TGF-β Alters the Proportion of Infiltrating Immune Cells in a Pancreatic Ductal Adenocarcinoma.转化生长因子-β改变胰腺导管腺癌中浸润免疫细胞的比例。
J Gastrointest Surg. 2022 Jan;26(1):113-121. doi: 10.1007/s11605-021-05087-x. Epub 2021 Jul 14.
7
Mechanism of action of PD-1 receptor/ligand targeted cancer immunotherapy.PD-1 受体/配体靶向癌症免疫疗法的作用机制。
Eur J Immunol. 2021 Aug;51(8):1911-1920. doi: 10.1002/eji.202048994. Epub 2021 Jun 21.
8
Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapy.用于增强癌症免疫疗法中抗原特异性 T 细胞扩增的生物材料。
Biomaterials. 2021 Jan;268:120584. doi: 10.1016/j.biomaterials.2020.120584. Epub 2020 Dec 5.
携带CCR7的CD103(+)/CD141(+)树突状细胞在黑色素瘤肿瘤抗原转运及T细胞免疫启动中的关键作用
Cancer Cell. 2016 Aug 8;30(2):324-336. doi: 10.1016/j.ccell.2016.06.003. Epub 2016 Jul 14.